ORRV CEO Email - corrected:
Hi Frank -
All jokes
ORRV CEO Email - corrected:
Hi Frank -
All jokes aside, here are some legitimate questions:
1) Has your new TA already provided final information requested by FINRA?
2) Or do you still have to send more documentation to FINRA?
3) exactly how many days did FINRA tell you it would take to post TICKER CHANGE to MCCU?
4) Why no PRs in weeks or a month?
5) No sales revenue progress?
6) Are you holding material information like revenue increase/updates until the day ticker changes?
Come on Frank - I have a friend who owns $30K @ $.0016 average. I am so embarrassed that I actually recommended your stock based on your p[romises and timelines - it has been months with no significant price change. Loyal traders should be rewarded with some actual answers to these questions so that they can load or reload and be ready to get some of their money back from holding these losing bags for months.
Since March 24th, only 4 days with price over .0015 - Very sad for a promising public shell launch - in my opinion, most of these problems could have been avoided by decent legal representation and somebody inside that simply took the time to read your legal filings for Christ sake! So many typographical and factual errors in the early posted legal R/M filings showed very sloppy internal processes and legal work - i can only imagine these sloppy errors continue to plague the company - never seen any OTC company take this amount of time to complete a simple R/S. Also, have you counted how many dozens of Tweets stated "Press Release to follow" and never followed? This type of irresponsible behavior has cost this stock and its traders/investors very avoidable losses of what should have been a moving average of at least $.01 since March. Very sad and very avoidable. What has changed at your end Frank? This ticker has lost massive cred. Just plain sucks! You should hear the truth. I believe that I just delivered to you the hard truth. Now, what are you going to do about it?
I sense that all the screwups and missed promotional opportunities have already relegated ORRV to be foprever stuck at low OTC sub-penny prices - because traders don't forget all of the undelivered promises. ORRV/MCCU could and should have been oh so special and selling in the penny to teens - what a sad wasted opportunity bungled by a group who obviosly did not listen to the customer who buys this stock - many ried to advise you (correctly) to tighten up your legal representation, deliver on your promises come hell or jhigh water, but instead your company dilluted the crap out of the "small insificant investor".
One BIG LIE I need to mention - you promised to retire 1 to 2 billion shares months ago. Nothing has been done to make this happen - it is NOT a difficult process - give any one of the average traders the task and it would been done months ago. Instead you guys diluted the stock for months to the tune of billions of triple zero shares day after day, week after week. Now that you guys got your debts paid off by diluting loyal early shareholders, you haven't lifted a finger to do crap to deliver on your promises. Sad.
Sincerely disappointed,
2
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...
Continue Reading
A Steady March Forward for Yum China Yum China's third-quarter results reveal a company moving like a well-oiled machine, even in a turbulent market. A revenue uptick of 8% is no small feat, especially when operating under the weight of a 3% rise in system sales that neatly sidesteps the usual foreign exchange hiccups. This ain't just about keeping the lights on; it's...
Continue Reading
OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...
Continue Reading
Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...
Continue Reading
Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...
Continue Reading
Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...
Continue Reading
New Leadership at PASCO scientific Here's the scoop: PASCO scientific is shaking things up at the top by welcoming David Lopez into the CEO chair as of October 5, 2026. Lopez comes packing over two decades of experience in education and organizational leadership. He's stepping into a legacy that's all about making science hands-on and exciting for students—not just in...
Continue Reading
Graphic Packaging's Financial Figures: A Rough Ride Looking at the latest numbers from Graphic Packaging (NYSE: GPK), it's clear that the packaging landscape isn’t all wrapped up in a neat bow. Sure, the top line showed a slight uptick year-on-year with net sales nudging up $2 million to $2,192 million. Volumes were up too—by 1%—but that’s barely a blip when you...
Continue Reading
Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...
Continue Reading
CPQ Tech: Unpacking the 2026 Manufacturing Landscape In the cutthroat world of manufacturing, it's adapt or die. Right now, happens it's the fixers in Configure, Price, Quote (CPQ) technology, stepping in to save the day. Nucleus Research just dropped their 2026 Manufacturing CPQ Technology Value Matrix, shining a bright spotlight on who’s leading the pack and why it...
Continue Reading
Top 5 Most Recently Viewed Articles
Introducing The Sylvan Lodge The Sylvan Lodge, nestled within the enchanting Snake River Sporting Club, provides an upscale retreat for those seeking an intimate escape in the stunning wilderness of Wyoming. This luxury lodge boasts serene views, a comprehensive spa, and wellness center, along with various dining experiences that elevate the guest experience to new...
Continue Reading
Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...
Continue Reading
Celebrating Excellence in Dermatologic Surgery Advocacy The American Society for Dermatologic Surgery Association (ASDSA), a leading organization advocating for dermatologic surgeons and their patients, has proudly announced its annual award recipients. This announcement highlights the essential contributions made by individuals who play pivotal roles in promoting patient...
Continue Reading
Scholastic Appoints Chris Lick to Leadership Role Scholastic (NASDAQ: SCHL) has recently announced a significant leadership change within its ranks, as Chris Lick steps into the role of Executive Vice President, General Counsel, and Corporate Secretary. This strategic appointment marks a new chapter for Scholastic, one of the leading organizations in children's publishing...
Continue Reading
Pandora Unveils New Share Buyback Programme On February 7, 2024, Pandora revealed a detailed share buyback programme that underscores its dedication to enhancing shareholder value. This initiative complies with Regulation (EU) No 596/2014, which sets the standards for market abuse regulations. Aims of the Share Buyback Programme The main objective of this programme is to...
Continue Reading